03.03.2015 Views

Disease staging: CliniCal anD CoDeD Criteria - HCUP

Disease staging: CliniCal anD CoDeD Criteria - HCUP

Disease staging: CliniCal anD CoDeD Criteria - HCUP

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Clinical <strong>Criteria</strong> with Description, Diagnostic Findings and ICD-9-CM codes<br />

DXCat Number: RES10<br />

MultiStage: No<br />

DXCat Label: Hypersensitivity Pneumonitis Specificity: A<br />

Etiology: Immune; Toxicologic<br />

Stage Description Diagnostic findings ICD-9-CM Codes<br />

1.01 Acute hypersensitivity pneumonitis or History of exposure to allergen<br />

DX 4950-4959;<br />

farmer's lung or bagassosis or birdfancier's<br />

AND precipitating antibody to allergen [serology report]<br />

lung or suberosis or malt worker's AND diffuse granulomatous interstitial pneumonitis [operative/pathology report or biopsy report<br />

lung or mushroom worker's lung or maple or chest x-ray report]<br />

bark-stripper's lung or other extrinsic<br />

allergic alveolitis<br />

AND improvement in pneumonia with cessation of allergen exposure<br />

1.02 with subacute hypersensitivity pneumonitis Stage 1.01<br />

AND subacute hypersensitivity pneumonitis<br />

OR chronic time span:<br />

symptoms or signs persists ≥ 3months/ year<br />

AND cough<br />

AND malaise<br />

AND dyspnea<br />

AND sputum production<br />

2.01 with restrictive lung disease Stage 1.01<br />

AND restrictive lung disease:<br />

2.02 with diffuse interstitial fibrosis Stage 1.01-2.01<br />

AND diffuse interstitial fibrosis [chest x-ray report]<br />

3.01 with cor pulmonale Stage 1.01-2.02<br />

AND cor pulmonale:<br />

3.02 with respiratory failure Stage 1.01-3.01<br />

AND respiratory failure:<br />

3.03 with shock Stage 1.01-3.02<br />

AND shock:<br />

4.00 with death Stage 2.01-3.03<br />

AND death<br />

NO;<br />

NO;<br />

STAGE 1.01 + DX 515;<br />

STAGE 1.01-2.02 + GROUP<br />

COR_PULMONAL;<br />

STAGE 1.01-3.01 + GROUP<br />

RESP_FAIL;<br />

STAGE 1.01-3.02 + (GROUP<br />

SHOCKC OR GROUP SHOCKN) ;<br />

NO;<br />

References:<br />

Greenberger PA. Immunologic aspects of lung diseases and cystic fibrosis. JAMA. 1997;278(22):1924-30.<br />

Hunninghake GW, Richerson HB. Hypersensitivity pneumonitis and eosinophilic pneumonias. In: Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL, Hauser<br />

SL, Longo DL, eds. Harrison's Principles of Internal Medicine. 14th ed. New York, NY: McGraw-Hill; 1998:1426-1429.<br />

Madan I. ABC of work related disorders. occupational asthma and other respiratory diseases. BMJ. 1996;313(7052):291-4.<br />

Stauffer JL. Lung. In: Tierney Jr LM, McPhee SJ, Papadakis MA, eds. Current Medical Diagnosis & Treatment. Stamford, CT: Appleton & Lange; 1998:251-333.<br />

Stern RC. Hypersensitivity to inhaled materials. In: Behrman RE, Kliegman RM, Arvin AM, Nelson WE, eds. Nelson Textbook of Pediatrics. 15th ed. Philadelphia, PA: WB<br />

Saunders; 1996:1218.<br />

Thursday, January 07, 2010 9:23:11 AM<br />

©2010 Thomson Reuters. All rights reserved.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!